U.S. News

FDA Probes Hospitalizations Linked to Fake Ozempic: Report

SCARY

Supplies of the legitimate medication are in short supply amid rocketing demand.

Pens for the diabetes drug Ozempic sit on a production line to be packaged at Danish drugmaker Novo Nordisk’s site in Hillerod, Denmark, Sept. 26, 2023.
Tom Little/Reuters